Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 4/20 | 0.70 |
| ▸ | LMNA | P02545 | 3/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | SHBG | P04278 | 2/20 | 0.70 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.70 |
| ▸ | G6PD | P11413 | 2/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.70 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.70 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.70 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | ABL1 | P00519 | 1/20 | 0.51 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.51 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4892804 | 1.00 | GPBAR1 (0.70) | GPBAR1LMNACYP3A4MEN1KMT2A | |
| SCHEMBL3362889 | 1.00 | GPBAR1 (0.70) | GPBAR1LMNACYP3A4MEN1KMT2A | |
| SCHEMBL11004575 | 1.00 | GPBAR1 (0.70) | GPBAR1LMNACYP3A4MEN1KMT2A | |
| SCHEMBL15463390 | 1.00 | GPBAR1 (0.70) | GPBAR1LMNACYP3A4MEN1KMT2A | |
| SCHEMBL20058395 | 1.00 | GPBAR1 (0.70) | GPBAR1LMNACYP3A4MEN1KMT2A | |
| SCHEMBL4890316 | 1.00 | GPBAR1 (0.70) | GPBAR1LMNACYP3A4MEN1KMT2A | |
| SCHEMBL6938662 | 1.00 | GPBAR1 (0.70) | GPBAR1LMNACYP3A4MEN1KMT2A | |
| SCHEMBL1800894 | 1.00 | GPBAR1 (0.70) | GPBAR1LMNACYP3A4MEN1KMT2A | |
| SCHEMBL14525640 | 1.00 | GPBAR1 (0.70) | GPBAR1LMNACYP3A4MEN1KMT2A | |
| SCHEMBL4893508 | 1.00 | GPBAR1 (0.70) | GPBAR1LMNACYP3A4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7951890-B2 | Using epichlorohydrin to form gel; pulverization; mixing with buffer solution and hydrolases; stirring; centrifuging | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2011-05-31 | — | — | US | claimed |
| US-20080207931-A1 | Solid-Phase Extraction Method of Steroid Hormones by Entrapped Beta-Cyclodextrin Polymers | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-08-28 | — | — | US | claimed |
| US-20260066076-A1 | METHODS AND SYSTEMS FOR DETERMINING A PRESCRIPTIVE THERAPY INSTRUCTION SET | KPN INNOVATIONS LLC (US) | 2026-03-05 | — | — | US | disclosed |
| US-20250378930-A1 | METHODS AND SYSTEMS FOR GENERATING LIFESTYLE CHANGE RECOMMENDATIONS BASED ON BIOLOGICAL EXTRACTIONS | KPN INNOVATIONS LLC (US) | 2025-12-11 | — | — | US | disclosed |
| US-20250363397-A1 | METHODS AND SYSTEMS FOR PHYSIOLOGICALLY INFORMED GESTATIONAL INQUIRIES | KPN INNOVATIONS LLC (US) | 2025-11-27 | — | — | US | disclosed |
| US-20250349438-A1 | METHODS AND SYSTEMS FOR OPTIMIZING SUPPLEMENT DECISIONS | KPN INNOVATIONS LLC (US) | 2025-11-13 | — | — | US | disclosed |
| US-12431228-B2 | Methods and systems for determining a prescriptive therapy instruction set | KPN INNOVATIONS LLC (US) | 2025-09-30 | — | — | US | disclosed |
| US-12417836-B2 | Apparatus and method for scoring a nutrient | KPN INNOVATIONS LLC (US) | 2025-09-16 | — | — | US | disclosed |
| US-20250278768-A1 | SYSTEMS AND METHODS FOR GENERATING A CUSTOMIZED BADGE | KPN INNOVATIONS, LLC (US) | 2025-09-04 | — | — | US | disclosed |
| US-12405959-B2 | Methods and systems for arranging and displaying guided recommendations via a graphical user interface based on biological extraction | KPN INNOVATIONS LLC (US) | 2025-09-02 | — | — | US | disclosed |
| US-12406360-B2 | Artificial intelligence methods and systems for analyzing imagery | KPN INNOVATIONS, LLC. (US) | 2025-09-02 | — | — | US | disclosed |
| US-20200321113-A1 | SYSTEMS AND METHODS FOR GENERATING ALIMENTARY INSTRUCTION SETS BASED ON VIBRANT CONSTITUTIONAL GUIDANCE | KPN INNOVATIONS, LLC | 2020-10-08 | — | — | US | disclosed |
| US-20200321114-A1 | METHODS AND SYSTEMS FOR SELF-FULFILLMENT OF AN ALIMENTARY INSTRUCTION SET BASED ON VIBRANT CONSTITUTIONAL GUIDANCE | KPN INNOVATIONS, LLC | 2020-10-08 | — | — | US | disclosed |
| US-20200321116-A1 | METHODS AND SYSTEMS FOR GENERATING AN ALIMENTARY INSTRUCTION SET IDENTIFYING AN INDIVIDUAL PROGNOSTIC MITIGATION PLAN | KPN INNOVATIONS, LLC. | 2020-10-08 | — | — | US | disclosed |
| US-10734105-B1 | Methods and systems for informed selection of prescriptive therapies | KPN INNOVATIONS, LLC | 2020-08-04 | — | — | US | disclosed |
| US-10734096-B1 | Methods and systems for optimizing supplement decisions | KPN INNOVATIONS, LLC | 2020-08-04 | — | — | US | disclosed |
| US-7951890-B2 | Using epichlorohydrin to form gel; pulverization; mixing with buffer solution and hydrolases; stirring; centrifuging | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2011-05-31 | — | — | US | disclosed |
| US-7745558-B2 | Entrapped β-cyclodextrin polymer and a method of preparing the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-06-29 | — | — | US | disclosed |
| US-20080207931-A1 | Solid-Phase Extraction Method of Steroid Hormones by Entrapped Beta-Cyclodextrin Polymers | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-08-28 | — | — | US | disclosed |
| US-20080194784-A1 | Entrapped Beta-Cyclodextrin Polymer and a Method of Preparing the Same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260066076-A1 | METHODS AND SYSTEMS FOR DETERMINING A PRESCRIPTIVE THERAPY INSTRUCTION SET | SET, SLTM, LIFR | GPBAR1 1623/4885LMNA 3649/4885CYP3A4 1851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.